307 related articles for article (PubMed ID: 27068332)
1. Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
BMC Cardiovasc Disord; 2016 Apr; 16():66. PubMed ID: 27068332
[TBL] [Abstract][Full Text] [Related]
2. Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.
Derosa G; Mugellini A; Querci F; Franzetti I; Pesce RM; D'Angelo A; Maffioli P
Sci Rep; 2015 Aug; 5():12603. PubMed ID: 26243165
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
[TBL] [Abstract][Full Text] [Related]
4. Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.
Lins R; Haerden Y; de Vries C
High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):29-36. PubMed ID: 28058623
[TBL] [Abstract][Full Text] [Related]
5. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
6. Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients.
Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
Eur J Pharmacol; 2015 Nov; 766():31-6. PubMed ID: 26407654
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study.
Parati G; Giglio A; Lonati L; Destro M; Ricci AR; Cagnoni F; Pini C; Venco A; Maresca AM; Monza M; Grandi AM; Omboni S
Clin Ther; 2010 Jul; 32(7):1270-84. PubMed ID: 20678675
[TBL] [Abstract][Full Text] [Related]
8. Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.
Spirou A; Rizos E; Liberopoulos EN; Kolaitis N; Achimastos A; Tselepis AD; Elisaf M
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):256-61. PubMed ID: 17220472
[TBL] [Abstract][Full Text] [Related]
9. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
James IG; Jones A; Davies P
J Hum Hypertens; 2002 Aug; 16(8):605-10. PubMed ID: 12149668
[TBL] [Abstract][Full Text] [Related]
11. Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study.
Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
J Am Soc Hypertens; 2014 Jun; 8(6):422-8. PubMed ID: 24836352
[TBL] [Abstract][Full Text] [Related]
12. Effects of barnidipine in comparison with hydrochlorothiazide on endothelial function, as assessed by flow mediated vasodilatation in hypertensive patients.
Muiesan ML; Salvetti M; Belotti E; Paini A; Rosei CA; Aggiusti C; Scotti A; de Ciuceis C; Rizzoni D; Rosei EA
Blood Press; 2011 Aug; 20(4):244-51. PubMed ID: 21332412
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin on the antihypertensive activity of losartan in hypertensive hypercholesterolemic animals and patients: role of nitric oxide, oxidative stress, and high-sensitivity C-reactive protein.
Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
Fundam Clin Pharmacol; 2014 Jun; 28(3):237-48. PubMed ID: 23488690
[TBL] [Abstract][Full Text] [Related]
15. Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.
Rachmani R; Levi Z; Zadok BS; Ravid M
Clin Pharmacol Ther; 2002 Sep; 72(3):302-7. PubMed ID: 12235451
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
[TBL] [Abstract][Full Text] [Related]
17. Lercanidipine in the treatment of hypertension.
Beckey C; Lundy A; Lutfi N
Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
[TBL] [Abstract][Full Text] [Related]
18. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
19. Effects of AT1 receptor antagonist losartan on sICAM-1 and TNF-alpha levels in uncomplicated hypertensive patients.
Sardo MA; Castaldo M; Cinquegrani M; Bonaiuto M; Fontana L; Campo S; Campo GM; Altavilla D; Saitta A
Angiology; 2004; 55(2):195-203. PubMed ID: 15026875
[TBL] [Abstract][Full Text] [Related]
20. How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.
Tocci G; Desideri G; Roca E; Calcullo C; Crippa M; De Luca N; Gaudio GV; Lonati LM; Orselli L; Scuteri A; Vulpis V; Acone B; Zaninelli A;
High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):25-34. PubMed ID: 29197935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
